Selected research
Industry Research
Rheolytic Thrombectomy Industry Research Report 2026
Market perspective
The global Rheolytic Thrombectomy market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Rheolytic Thrombectomy market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Rheolytic Thrombectomy market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Rheolytic Thrombectomy market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Rheolytic Thrombectomy include Abbott Laboratories, Koninklijke Philips N.V., Terumo Corporation, Boston Scientific Group, Medtronic plc, AngioDynamics, Penumbra Inc., Stryker Corporation and Teleflex Incorporated and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Rheolytic Thrombectomy market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Rheolytic Thrombectomy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Rheolytic Thrombectomy Market by Company
Abbott Laboratories
Koninklijke Philips N.V.
Terumo Corporation
Boston Scientific Group
Medtronic plc
AngioDynamics
Penumbra Inc.
Stryker Corporation
Teleflex Incorporated
Johnson and Johnson
Rheolytic Thrombectomy Segment by Type
Automated Devices
Manual Devices
Rheolytic Thrombectomy Segment by Application
Peripheral Diseases
Coronary Disease
Neural Diseases
Rheolytic Thrombectomy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rheolytic Thrombectomy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rheolytic Thrombectomy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rheolytic Thrombectomy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Rheolytic Thrombectomy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Automated Devices
- Manual Devices
Applications
- Peripheral Diseases
- Coronary Disease
- Neural Diseases
Companies covered
- Abbott Laboratories
- Koninklijke Philips N.V.
- Terumo Corporation
- Boston Scientific Group
- Medtronic plc
- AngioDynamics
- Penumbra Inc.
- Stryker Corporation
- Teleflex Incorporated
- Johnson and Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Rheolytic Thrombectomy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Automated Devices
- 2.2.3 Manual Devices
- 2.3 Rheolytic Thrombectomy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Peripheral Diseases
- 2.3.3 Coronary Disease
- 2.3.4 Neural Diseases
- 2.4 Assumptions and Limitations
3 Rheolytic Thrombectomy Breakdown Data by Type
- 3.1 Global Rheolytic Thrombectomy Historic Market Size by Type (2021-2026)
- 3.2 Global Rheolytic Thrombectomy Forecasted Market Size by Type (2027-2032)
4 Rheolytic Thrombectomy Breakdown Data by Application
- 4.1 Global Rheolytic Thrombectomy Historic Market Size by Application (2021-2026)
- 4.2 Global Rheolytic Thrombectomy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Rheolytic Thrombectomy Market Perspective (2021-2032)
- 5.2 Global Rheolytic Thrombectomy Growth Trends by Region
- 5.2.1 Global Rheolytic Thrombectomy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Rheolytic Thrombectomy Historic Market Size by Region (2021-2026)
- 5.2.3 Rheolytic Thrombectomy Forecasted Market Size by Region (2027-2032)
- 5.3 Rheolytic Thrombectomy Market Dynamics
- 5.3.1 Rheolytic Thrombectomy Industry Trends
- 5.3.2 Rheolytic Thrombectomy Market Drivers
- 5.3.3 Rheolytic Thrombectomy Market Challenges
- 5.3.4 Rheolytic Thrombectomy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Rheolytic Thrombectomy Players by Revenue
- 6.1.1 Global Top Rheolytic Thrombectomy Players by Revenue (2021-2026)
- 6.1.2 Global Rheolytic Thrombectomy Revenue Market Share by Players (2021-2026)
- 6.2 Global Rheolytic Thrombectomy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Rheolytic Thrombectomy Head Office and Area Served
- 6.4 Global Rheolytic Thrombectomy Players, Product Type & Application
- 6.5 Global Rheolytic Thrombectomy Manufacturers Established Date
- 6.6 Global Rheolytic Thrombectomy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Rheolytic Thrombectomy Market Size (2021-2032)
- 7.2 North America Rheolytic Thrombectomy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 7.4 North America Rheolytic Thrombectomy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Rheolytic Thrombectomy Market Size (2021-2032)
- 8.2 Europe Rheolytic Thrombectomy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 8.4 Europe Rheolytic Thrombectomy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Rheolytic Thrombectomy Market Size (2021-2032)
- 9.2 Asia-Pacific Rheolytic Thrombectomy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Rheolytic Thrombectomy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Rheolytic Thrombectomy Market Size (2021-2032)
- 10.2 South America Rheolytic Thrombectomy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 10.4 South America Rheolytic Thrombectomy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Rheolytic Thrombectomy Market Size (2021-2032)
- 11.2 Middle East & Africa Rheolytic Thrombectomy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Rheolytic Thrombectomy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott Laboratories
- 12.1.1 Abbott Laboratories Company Information
- 12.1.2 Abbott Laboratories Business Overview
- 12.1.3 Abbott Laboratories Revenue in Rheolytic Thrombectomy Business (2021-2026)
- 12.1.4 Abbott Laboratories Rheolytic Thrombectomy Product Portfolio
- 12.1.5 Abbott Laboratories Recent Developments
- 12.2 Koninklijke Philips N.V.
- 12.2.1 Koninklijke Philips N.V. Company Information
- 12.2.2 Koninklijke Philips N.V. Business Overview
- 12.2.3 Koninklijke Philips N.V. Revenue in Rheolytic Thrombectomy Business (2021-2026)
- 12.2.4 Koninklijke Philips N.V. Rheolytic Thrombectomy Product Portfolio
- 12.2.5 Koninklijke Philips N.V. Recent Developments
- 12.3 Terumo Corporation
- 12.3.1 Terumo Corporation Company Information
- 12.3.2 Terumo Corporation Business Overview
- 12.3.3 Terumo Corporation Revenue in Rheolytic Thrombectomy Business (2021-2026)
- 12.3.4 Terumo Corporation Rheolytic Thrombectomy Product Portfolio
- 12.3.5 Terumo Corporation Recent Developments
- 12.4 Boston Scientific Group
- 12.4.1 Boston Scientific Group Company Information
- 12.4.2 Boston Scientific Group Business Overview
- 12.4.3 Boston Scientific Group Revenue in Rheolytic Thrombectomy Business (2021-2026)
- 12.4.4 Boston Scientific Group Rheolytic Thrombectomy Product Portfolio
- 12.4.5 Boston Scientific Group Recent Developments
- 12.5 Medtronic plc
- 12.5.1 Medtronic plc Company Information
- 12.5.2 Medtronic plc Business Overview
- 12.5.3 Medtronic plc Revenue in Rheolytic Thrombectomy Business (2021-2026)
- 12.5.4 Medtronic plc Rheolytic Thrombectomy Product Portfolio
- 12.5.5 Medtronic plc Recent Developments
- 12.6 AngioDynamics
- 12.6.1 AngioDynamics Company Information
- 12.6.2 AngioDynamics Business Overview
- 12.6.3 AngioDynamics Revenue in Rheolytic Thrombectomy Business (2021-2026)
- 12.6.4 AngioDynamics Rheolytic Thrombectomy Product Portfolio
- 12.6.5 AngioDynamics Recent Developments
- 12.7 Penumbra Inc.
- 12.7.1 Penumbra Inc. Company Information
- 12.7.2 Penumbra Inc. Business Overview
- 12.7.3 Penumbra Inc. Revenue in Rheolytic Thrombectomy Business (2021-2026)
- 12.7.4 Penumbra Inc. Rheolytic Thrombectomy Product Portfolio
- 12.7.5 Penumbra Inc. Recent Developments
- 12.8 Stryker Corporation
- 12.8.1 Stryker Corporation Company Information
- 12.8.2 Stryker Corporation Business Overview
- 12.8.3 Stryker Corporation Revenue in Rheolytic Thrombectomy Business (2021-2026)
- 12.8.4 Stryker Corporation Rheolytic Thrombectomy Product Portfolio
- 12.8.5 Stryker Corporation Recent Developments
- 12.9 Teleflex Incorporated
- 12.9.1 Teleflex Incorporated Company Information
- 12.9.2 Teleflex Incorporated Business Overview
- 12.9.3 Teleflex Incorporated Revenue in Rheolytic Thrombectomy Business (2021-2026)
- 12.9.4 Teleflex Incorporated Rheolytic Thrombectomy Product Portfolio
- 12.9.5 Teleflex Incorporated Recent Developments
- 12.10 Johnson and Johnson
- 12.10.1 Johnson and Johnson Company Information
- 12.10.2 Johnson and Johnson Business Overview
- 12.10.3 Johnson and Johnson Revenue in Rheolytic Thrombectomy Business (2021-2026)
- 12.10.4 Johnson and Johnson Rheolytic Thrombectomy Product Portfolio
- 12.10.5 Johnson and Johnson Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst